GEN-MKT-18-7897-A
Aug 7, 2017 | Blogs, Technology | 0 comments
Did you know you can access Knowledge Base Articles for trending user questions compiled and answered by SCIEX support experts? Doing so may help to reduce your support calls, not to mention downtime. Instead of waiting for a problem to occur, you can stay on top of it, and be a part of the solution. To give you an idea of trending articles, consider the how this past month saw questions and answers including:
As you will see, many of the new articles are focused on our SCIEX industry-leading software such as SCIEX OS and BioPharmaView. Make sure to visit the Knowledge Base to learn all the tips and trick so that you can get the max out of your software.
What is Premium Access Content?Now to the business of premium versus non-premium content. Premium Access Content is available to customers who own a mass spectrometer or CE instrument under warranty, or to anyone who has purchased a Software Support Plan. More specifically, the difference between premium and non-premium content is that premium content includes access to advanced workflows.
Knowledge Base Articles versus Community DiscussionsThe difference between the Knowledge Base Articles and Community Discussions is that Knowledge Base Articles come from the SCIEX support team and are based on common questions. If we see a trend in customer inquiries, the support team will create and post an article to help everyone out. Alternatively, the community is the ideal place to pose a question and get help from your peers. See a question that has yet to be answered?
Warranty expiration is more than an administrative milestone—it is a transition point that can significantly impact instrument uptime, laboratory productivity, operating budgets, and scientific outcomes.
For more than 20 years, the CDCO has supported academic, commercial, and not‑for‑profit drug discovery programs with deep expertise in pharmaceutical lead optimization. Within the bioanalytical group, their role is to enable rapid and reliable decision‑making through quantitative analysis of candidate drugs in biological matrices.
PFAS are increasingly at the center of regulatory change, scientific research, and industry discussion worldwide. As analytical capabilities improve and expectations around environmental responsibility continue to evolve, understanding the role PFAS play, and how they are being addressed, has never been more important. This blog provides an overview of what PFAS are, why they matter, and how responses from regulators and industry are changing.
Posted by
You must be logged in to post a comment.
Share this post with your network